not losing weight on semaglutide semaglutide? 7 Reasons Why You're Not

A pooled analysis of the STEP-HFpEF and STEP-HFpEF DM trials showed that semaglutide reduced the risk of the composite endpoint of cardiovascular death or heart failure events by 31% compared to placebo (HR: 0.69, 96%CI: 0.53-0.89

Increase oxygen and blood flow to the legs: Several studies suggest that peripheral hypoxia (low oxygen in the legs and arms) is contributing to RLS and PLMD

At $300 to $500 per month for compounded medications, a single bad experience means hundreds of dollars gone with nothing to show for it

Additionally, the FDA hasnt approved The concurrent use of Mounjaro with other GLP-1 medications is beneficial for people with type 2 diabetes

Quick Answer: Current evidence suggests a possible association between semaglutide and pancreatitis rather than a confirmed causal relationship, with clinical trials showing relatively low incidence rates